dysregulation of S-nitrosylation, a process that mediates proteins activity, contributes to the pathogenesis of this disorder. We aim to investigate detrusor function and cAMP activation as a possible treatment for detrusor overactivity in an experimental model lacking a key denitrosylation enzyme, S-nitrosoglutathione reductase (GSNOR).
INTRODUCTION AND OBJECTIVES: Detrusor Overactivity (DO) is the abnormal response of the urinary bladder to physiological stretch during the filling phase of the micturition cycle. Although the mechanisms underlying this response are poorly understood, increasing evidence suggest that TREK-1 channel, a mechanosensitive member of the two-pore potassium channel family (K2P, KCNK), is a key regulator of detrusor response to stretch. We hypothesized that changes in detrusor TREK-1 protein expression underlie excitability and force transduction alterations in DO. We aimed to: 1) study the changes in expression and function of TREK-1 channels and, 2) explore the basis of TREK-1 force transduction under pathological conditions associated with detrusor overactivity (DO) in the human detrusor.
METHODS: We performed immunocytochemistry labeling, qRT-PCR, whole cell patch-clamp electrophysiological recordings and detrusor muscle strip contractility studies on freshly dissociated bladder smooth cells isolated from normal (AUA SS <8; n¼ 15) and DO (AUA SS >22; n¼ 33) human bladders.
RESULTS: A two-fold depletion in TREK-1 channel protein expression was observed in specimens obtained from DO bladders in comparison to controls (4.6AE2.1 vs 9.1AE2.7. 0.05). This change was associated with a significant reduction of whole cell patch-clamp recorded TREK-1 currents (Control, 1087.0AE99.3 pApF vs DO, 98.6AE66.3 pApF at 60 mV, n¼6 each. 0.001). Further, detrusor strips obtained from DO patients failed to relax when exposed to 10 mM of arachidonic acid, a TREK-1 channel opener. To study how the mechanical force is transduced, we performed confocal analysis of immunocytochemically labeled freshly dissociated detrusor smooth muscle cells against cytoskeletal elements. Our results revealed colocalization of TREK-1 channels with members of the caveolin protein family and cytoskeletal proteins. Interestingly, caveolae microdomains were severely disrupted in DO specimens.
CONCLUSIONS: Our data demonstrate a significant reduction of TREK-1 channel expression and function in human smooth muscle cells obtained from DO bladders. Further, we provided evidence of close association between TREK-1 channels, different elements of the cell cytoskeleton and caveolins suggesting the presence of TREK-1 enriched caveolae microdomains. The underling pathologies for many of these diseases are poorly understood. To better delineate the role of sensory nerve fibers in bladder function, we have utilized optogenetics to spatially and temporally control bladder afferent activity.
Source of Funding
METHODS: Optogenetics involves the use of optically activatable pumps, channels or receptors (opsins) expressed in neurons to modulate their activity. We crossed mice expressing the Cre-dependent genes for the excitatory opsin channelrhodopsin-2 (ChR2) and the inhibitory archaerhodopsin (Arch) with mice that express Cre recombinase in Nav 1.8 or TRPV1 populations to restrict expression to e1350 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 
